Search Videos by Topic or Participant
Browse by Series:

Effective Management of Prostate Cancer Conclusion

Panelists: Raoul S. Concepcion, MD, Urology Associates, PC; Steve Dobbs, Urologic Associates of Oklahoma; Bryan A. Mehlhaff, MD, Oregon Urology Institute;
Published: Thursday, Feb 21, 2013
For High-Definition, Click
In this segment, Raoul Concepcion, MD, wraps up the discussion by noting that conversations often provide urologists with the opportunity to stay involved and provide new points of view to their peers. In closing, Daniel R. Saltzstein, MD, Bryan Mehlhaff, MD, and Steve Dobbs, FACHE, each provide their opinions on key areas of interest in prostate cancer.

Saltzstein notes that a few different areas of prostate cancer are in need of further development, such as biopsying, surveillance, radiation, surgery, and androgen deprivation therapy. With all the recent advances and new treatments approved, it's an exciting time in prostate cancer, Mehlhaff points out. However, he adds, finding a cure for the disease should remain a goal of research. In terms of reimbursement and purchasing costs, Dobbs stresses that communication and trust between physicians is an important factor.
Slider Left
Slider Right
For High-Definition, Click
In this segment, Raoul Concepcion, MD, wraps up the discussion by noting that conversations often provide urologists with the opportunity to stay involved and provide new points of view to their peers. In closing, Daniel R. Saltzstein, MD, Bryan Mehlhaff, MD, and Steve Dobbs, FACHE, each provide their opinions on key areas of interest in prostate cancer.

Saltzstein notes that a few different areas of prostate cancer are in need of further development, such as biopsying, surveillance, radiation, surgery, and androgen deprivation therapy. With all the recent advances and new treatments approved, it's an exciting time in prostate cancer, Mehlhaff points out. However, he adds, finding a cure for the disease should remain a goal of research. In terms of reimbursement and purchasing costs, Dobbs stresses that communication and trust between physicians is an important factor.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x